Abcam Plc Stock Fundamentals

ABCMDelisted Stock  USD 23.59  0.56  2.32%   
Abcam PLC fundamentals help investors to digest information that contributes to Abcam PLC's financial success or failures. It also enables traders to predict the movement of Abcam Stock. The fundamental analysis module provides a way to measure Abcam PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abcam PLC stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Abcam PLC Company Current Valuation Analysis

Abcam PLC's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Abcam PLC Current Valuation

    
  5.63 B  
Most of Abcam PLC's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abcam PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Abcam PLC has a Current Valuation of 5.63 B. This is 60.77% lower than that of the Biotechnology sector and 21.29% higher than that of the Health Care industry. The current valuation for all United States stocks is 66.11% higher than that of the company.

Abcam PLC Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Abcam PLC's current stock value. Our valuation model uses many indicators to compare Abcam PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abcam PLC competition to find correlations between indicators driving Abcam PLC's intrinsic value. More Info.
Abcam PLC is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  12.46  of Return On Asset per Return On Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value Abcam PLC by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Abcam Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abcam PLC's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abcam PLC could also be used in its relative valuation, which is a method of valuing Abcam PLC by comparing valuation metrics of similar companies.
Abcam PLC is currently under evaluation in current valuation category among its peers.

Abcam Fundamentals

About Abcam PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abcam PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abcam PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abcam PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom. Abcam Plc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1682 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Abcam Stock

If you are still planning to invest in Abcam PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abcam PLC's history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments